Context: Usefulness of circulating Chromogranin A (CgA) for the diagnosis of neuroendocrine tumors (NEN) is controversial. The aim of the present study was to assess the actual role of this marker as diagnostic tool. Methods: Serum blood samples were obtained from 42 subjects affected with NEN, 120 subjects affected with non-endocrine neoplasias (non-NEN) and 100 non-neoplastic subjects affected with benign nodular goitre (NNG). Determination of CgA was performed by means of immunoradiometric assay. Results: The CgA levels among NEN-patients were not significantly different from NNG and non-NEN subjects. The Receiver operating characteristic (ROC) curves analysis failed to identify a feasible cut-off value for the differential diagnosis between NEN and the other conditions. Conclusion: Serum CgA is not helpful for the first-line diagnosis of NEN.

Limitations of Chromogranin A in clinical practice / Marotta, V; Nuzzo, V; Ferrara, T; Zuccoli, A; Masone, M; Nocerino, L; Del Prete, M; Marciello, F; Ramundo, V; Lombardi, G; Vitale, M; Colao, A; Faggiano, Antongiulio. - In: BIOMARKERS. - ISSN 1354-750X. - STAMPA. - 17:(2012), pp. 186-191. [10.3109/135475X.2012.654511]

Limitations of Chromogranin A in clinical practice.

FAGGIANO, ANTONGIULIO
2012

Abstract

Context: Usefulness of circulating Chromogranin A (CgA) for the diagnosis of neuroendocrine tumors (NEN) is controversial. The aim of the present study was to assess the actual role of this marker as diagnostic tool. Methods: Serum blood samples were obtained from 42 subjects affected with NEN, 120 subjects affected with non-endocrine neoplasias (non-NEN) and 100 non-neoplastic subjects affected with benign nodular goitre (NNG). Determination of CgA was performed by means of immunoradiometric assay. Results: The CgA levels among NEN-patients were not significantly different from NNG and non-NEN subjects. The Receiver operating characteristic (ROC) curves analysis failed to identify a feasible cut-off value for the differential diagnosis between NEN and the other conditions. Conclusion: Serum CgA is not helpful for the first-line diagnosis of NEN.
2012
Limitations of Chromogranin A in clinical practice / Marotta, V; Nuzzo, V; Ferrara, T; Zuccoli, A; Masone, M; Nocerino, L; Del Prete, M; Marciello, F; Ramundo, V; Lombardi, G; Vitale, M; Colao, A; Faggiano, Antongiulio. - In: BIOMARKERS. - ISSN 1354-750X. - STAMPA. - 17:(2012), pp. 186-191. [10.3109/135475X.2012.654511]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/560215
Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 55
  • ???jsp.display-item.citation.isi??? ND
social impact